Lacosamide Injection, Solution
Product Images NDC 25021-791

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 25021-791). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lac04 0002 01)

Chemical structure of lacosamide, showing its molecular arrangement including amide, ester, and phenyl functional groups as part of the intravenous injection solution product. The structural formula highlights the specific bonding and molecular configuration characteristic of lacosamide.*

FDA Label Image

Figure 1 (Lac04 0002 02)

A bar graph comparing seizure reduction (median percentage change from baseline) across three studies. It shows results for placebo and varying doses of lacosamide (200, 400, 600 mg/day) with sample sizes indicated. Statistically significant reductions compared to placebo are marked for lacosamide doses in each study.*

FDA Label Image

Figure 2 (Lac04 0002 03)

A responder rate curve graph showing the percentage of patients achieving equal to or greater improvement versus worsening. The x-axis represents the percent of patients, and the y-axis shows responder rate with improvement and worsening separated by a zero baseline. Four curves compare placebo and three doses of lacosamide (200 mg/day, 400 mg/day, and 600 mg/day) with sample sizes noted for each group.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Lac04 0002 04)

Label for Lacosamide Injection, USP 200 mg per 20 mL (10 mg per mL) intravenous solution, provided in a 20 mL single-dose vial. The label includes dosage instructions, storage temperatures, manufacturer (Sagent Pharmaceuticals), and barcode details. It states the product is for intravenous use only and includes warnings to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.